Assessment of HER2 status in extramammary Paget disease and its implication for disitamab vedotin, a novel humanized anti-HER2 antibody-drug conjugate therapy.
Front Med
; 18(3): 565-569, 2024 Jun.
Article
in En
| MEDLINE
| ID: mdl-38743132
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Paget Disease, Extramammary
/
Receptor, ErbB-2
/
Immunoconjugates
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Front Med
Year:
2024
Document type:
Article
Affiliation country:
China